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124* Exhaled NO and exhaled breath condensate in patients with
cystic ﬁbrosis and healthy controls
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Airway inﬂammation plays a key role in the pathogenesis of cystic ﬁbrosis (CF) and
results from a combination of repeated bacterial lung infection and an exaggerated
host response. The aim of this study was to assess exhaled NO and exhaled breath
condensate (EBC) pH to study airway inﬂammation in CF patients and controls.
Samples were collected from 32 CF patients, of which 9 were chronically colonized
with Pseudomonas aeruginosa (PA) and 21 healthy controls (age 6−23 yrs). NO was
measured with a NIOX Mino (Aerocrine), EBC was collected using a RTube (Res-
piratory Research; 15 min tidal breathing). pH was measured without deaeration.
NO was signiﬁcantly lower in CF compared to controls (median: 8 (interquartile
range (IQR) 6−10) versus 10 (IQR 9−16) ppb respectively; p = 0.003). There was
a signiﬁcant difference between CF with and without PA (6 (IQR 3−7) vs 8 (IQR
7−10) ppb respectively; p = 0.003). Heavier (p< 0.01) and taller (p< 0.01) children
had higher NO values. EBC pH was lower in CF patients than in controls (median:
5.38 (IQR 5.06−5.65) vs 5.70 (IQR 5.25−6.07) respectively), but this was not
signiﬁcant. Females had lower EBC pH than males (p = 0.03). Collected volume
EBC was signiﬁcantly higher in controls (median 1.7ml; IQR 1.5−2.0) compared
to CF patients (1.4ml; IQR 1.0−1.6; p = 0.04). Between the CF patients, the volume
was higher in CF with PA (1.6ml; IQR 1.3−2.0) vs CF without PA (1.2ml; IQR
0.9−1.6; p = 0.03). Older (p< 0.01), heavier (p = 0.04) and taller (p = 0.01) children
collected more EBC. In conclusion, signiﬁcant differences were observed for NO
between CF and healthy controls and CF with and without PA. EBC pH was lower
in CF, but this was not signiﬁcant.
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Cystic ﬁbrosis (CF) is caused by mutations in the gene encoding CF transmembrane
conductance regulator (CFTR). Mucus, a complex structure mainly composed of
water, ions and mucins, plays an important role in host defence against invading
pathogens. However, the mechanisms linking CFTR alteration to mucus overpro-
duction, observed in CF, remain unclear. Cytosolic phospholipase A2 (cPLA2) in
an enzyme which cleaves membrane phospholipids of mammalian cells leading
to a selective release of arachidonic acid (AA). We report here enhanced mucus
production associated to increased cPLA2 activity in lungs of CFTR−/− compared
to wild type mice. This was accompanied by an increased expression of a particular
mucin, Muc5ac. These processes were exacerbated by intranasal instillation of
Pseudomonas aeruginosa LPS and accompanied by increased concentrations of AA
in broncho-alveolar lavages ﬂuids. Mucus production was enhanced by intranasal
AA instillation. Disruption of the gene encoding cPLA2 or treating CFTR−/− mice
with a cPLA2 inhibitor abrogated mucus production and Muc5ac expression. Fi-
nally, enhanced cPLA2 activity and AA concentrations were evidenced in bronchial
explants of CF patients. We conclude that CFTR alteration in CF lungs induces an
abnormal cPLA2 activation, which in turn enhances mucus production via AA.
We propose a potential therapeutic role for cPLA2 inhibitors in reducing mucus
accumulation in CF. The signalling pathways involved in the induction of Muc5AC
expression in epithelial cells are under investigation.
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Background: Sphingolipid signalling may differ between individuals with CF and
healthy controls. The response to bacterial inﬂammation is different, and uptake
and inactivation of sphingosine-1-phosphate, an intracellular pro-inﬂammatory
mediator, is reduced in CF cells. It may therefore continue to act on G-protein
coupled receptors in the plasma membrane. (Boujaoude et al, J Biol Chem
2001). Furthermore, ceramide originating from basolateral sphingomyelin hinders
augmentation of CFTR-mediated anion conductance across the apical membrane,
resulting in reduction of transepithelial airway anion secretion (Ito et al, BBRC
2004).
Aim of study: To determine if there is a difference in the levels of alkaline, neutral
or acid sphingomyelinase (SMase), or in the levels of neutral or acid ceramidase, in
the intestinal or bronchial mucosa and some other tissues, between wildtype (+/+),
homozygous (−/−) and heterozygous (+/−) delta-F508 CFTR mice.
Methods: Enzyme activities (Duan and Nilsson Meth Enzymol 2000) were deter-
mined in intestine (and content) divided into four regions, liver, lungs, kidney and
spleen from deltaF508-CFTR mice (−/−) and controls (+/−, +/+).
Results: There was an increased amount of neutral ceramidase in spleens from
deltaF508-CFTR mice (−/−) in comparison to control mice (p = 0.0278). No other
signiﬁcant differences were seen.
Conclusion: Delta-F508 mutation did not inﬂuence the levels of alkaline SMase and
neutral ceramidases acting as ectoenzymes, or the levels of intracellular SMases and
ceramidases, which may all generate bioactive sphingolipid metabolites in intestine
and lungs. The implications of the increased level of neutral ceramidase in spleen
are not known.
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Oxidative stress is a complication of cystic ﬁbrosis (CF) lung disease. Upregulated
IL-8 production is reported to occur in the lung epithelium of CF patients. The
studies presented here compare the effects of oxidative stress on the nuclear factor
úB (NF-úB) and mitogen-activated protein (MAP) kinase signalling pathways,
which are mainly involved in the production of interleukin IL-8 and expression
of IL-8 related CXCR1/2 receptors, in two human CF airway epithelial cell
lines, IB3−1 (CFTR genotype F508del/W1282X) and CFBE41o-, (CFTR genotype
F508del/ F508del) and two non-CF human airway epithelial cell lines, the S9
cell line (IB3−1 cells corrected with wild-type CFTR) and the 16HBE14o- cell
line. Under prolonged oxidative stress, IL-8 production and the expression of the
CXCR1/2 receptors was increased in both CF and non-CF airway cells. Activation
of ERK1/2 was also observed in CF airway cells exposed to oxidative stress.
However, no transcriptional activation of NF-úB was detected when the CF cells
were compared to non-CF lung cells. The largest decrease of IL-8 production
and CXCR1/2 expression was observed in CF and non-CF airway cells when
sequentially exposed to oxidative stress and to UO126, the ERK1/2 inhibitor, or to
the NF-úB inhibitor, BAY 11–7082, respectively. The data support the notion that
the ERK1/2 MAP kinase is a key regulator of both IL-8 production and expression
of CXCR1/2 receptors in CF airway epithelial cells when exposed to prolonged
oxidative stress.
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